Controlled release formulation of clarithromycin or tinidazol

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/20 (2006.01) A61K 31/7048 (2006.01)

Patent

CA 2458776

The present invention relates to a controlled release pharmaceutical composition comprising amounts ranging from about 0.1 to about 4.5% w/w, of one or more of rate controlling cellulosic ether polymers.

L'invention concerne une composition pharmaceutique à libération contrôlée comprenant des quantités d'environ 0,1 à environ 4,5 % en poids d'un ou de plusieurs polymères d'éther cellulosiques de régulation de débit.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Controlled release formulation of clarithromycin or tinidazol does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release formulation of clarithromycin or tinidazol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release formulation of clarithromycin or tinidazol will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1720132

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.